Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Project: Every Child for Younger Patients With Cancer

NCT02402244

Conditions
Adrenal Gland Pheochromocytoma, Bone Marrow Diseases, Carcinoma, +59 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
View all 278 locations
View Trial Details
Recruiting

Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

NCT05848765

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • NHS Grampian Aberdeen, United Kingdom
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Blackpool Teaching Hospitals NHS Foundation Trust Blackpool, United Kingdom
View all 25 locations
View Trial Details
Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details
Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

NCT04870944

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 35 locations
View Trial Details
Recruiting

Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms

NCT06508931

Conditions
B-Cell Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Hôpital Robert Debré Paris, Boulevard Sérurier 48, France
  • Institut Gustave Roussy Villejuif, France
  • Universitaetsklinikum Muenster (UKM) - Klinik fuer Kinder- und Jugendmedizin - Paediatrische Haematologie und Onkologie Münster, Albert-Schweitzer-Campus 1, Gebaeude A1, Germany
  • IRCCS Ospedale Pediatrico Bambino Gesù Rome, Piazza Sant Onofrio 4, Italy
View Trial Details
Recruiting

A Dietary Study for People With Multiple Myeloma

NCT07226609

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details

Related conditions